Trident Lifeline (TLL) | Financial Analysis & Statements
Trident Lifeline Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
236.1M
Gross Profit
126.6M
53.63%
Operating Income
37.1M
15.70%
Net Income
27.8M
11.80%
EPS (Diluted)
₹2.66
Balance Sheet Metrics
Total Assets
1.9B
Total Liabilities
1.0B
Shareholders Equity
864.5M
Debt to Equity
1.16
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Trident Lifeline Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 869.6M | 446.3M | 316.9M | 217.7M | 96.2M |
| Cost of Goods Sold | 519.6M | 320.7M | 225.8M | 168.7M | 67.8M |
| Gross Profit | 350.0M | 125.6M | 91.2M | 49.0M | 28.4M |
| Gross Margin % | 40.2% | 28.1% | 28.8% | 22.5% | 29.5% |
| Operating Expenses | |||||
| Research & Development | 4.9M | 409.0K | 193.0K | 226.0K | - |
| Selling, General & Administrative | 50.8M | 9.1M | 5.8M | 7.5M | 7.0M |
| Other Operating Expenses | 3.0M | -1.6M | 36.1M | 70.0K | 197.0K |
| Total Operating Expenses | 58.7M | 7.9M | 42.1M | 7.8M | 7.2M |
| Operating Income | 114.9M | 80.7M | 62.1M | 26.0M | 11.1M |
| Operating Margin % | 13.2% | 18.1% | 19.6% | 11.9% | 11.5% |
| Non-Operating Items | |||||
| Interest Income | 18.8M | 14.6M | 7.6M | 0 | 14.0K |
| Interest Expense | 38.3M | 5.7M | 3.7M | 683.0K | 4.0M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 136.1M | 87.0M | 65.8M | 29.8M | 8.5M |
| Income Tax | 31.2M | 27.6M | 5.6M | -9.6M | 2.2M |
| Effective Tax Rate % | 22.9% | 31.7% | 8.6% | -32.3% | 26.0% |
| Net Income | 104.9M | 59.4M | 60.2M | 39.5M | 6.3M |
| Net Margin % | 12.1% | 13.3% | 19.0% | 18.1% | 6.6% |
| Key Metrics | |||||
| EBITDA | 188.0M | 108.5M | 76.2M | 33.5M | 13.9M |
| EPS (Basic) | ₹10.22 | ₹5.52 | ₹6.22 | ₹3.43 | ₹0.55 |
| EPS (Diluted) | ₹10.22 | ₹5.52 | ₹6.22 | ₹3.43 | ₹0.55 |
| Basic Shares Outstanding | 11499000 | 11499200 | 9658526 | 11499200 | 11499200 |
| Diluted Shares Outstanding | 11499000 | 11499200 | 9658526 | 11499200 | 11499200 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Trident Lifeline Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 24.6M | 66.5M | 137.8M | 1.6M | 935.0K |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 276.8M | 134.4M | 120.9M | 49.7M | 6.4M |
| Inventory | 282.4M | 125.8M | 71.7M | 37.1M | 52.7M |
| Other Current Assets | 15.3M | 21.0M | 26.9M | 624.0K | - |
| Total Current Assets | 903.7M | 519.7M | 492.1M | 106.7M | 77.4M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 62.9M | 30.5M | 3.6M | 422.0K | 423.0K |
| Goodwill | 94.8M | 45.5M | 26.4M | 11.3M | 8.1M |
| Intangible Assets | 84.3M | 45.5M | 25.9M | 11.3M | 8.1M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 56.0M | 19.7M | 6.7M | 328.0K | - |
| Total Non-Current Assets | 656.3M | 351.0M | 133.6M | 31.7M | 37.0M |
| Total Assets | 1.6B | 870.8M | 625.7M | 138.3M | 114.4M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 147.9M | 75.4M | 48.1M | 52.3M | 40.2M |
| Short-term Debt | 217.6M | 56.1M | 38.3M | 10.3M | 0 |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 110.8M | 10.6M | 14.6M | 1.0K | - |
| Total Current Liabilities | 535.5M | 202.6M | 115.3M | 75.7M | 73.4M |
| Non-Current Liabilities | |||||
| Long-term Debt | 322.7M | 128.0M | 38.6M | 14.2M | 45.3M |
| Deferred Tax Liabilities | 4.6M | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.0K | 702.0K | 1.0K | - | - |
| Total Non-Current Liabilities | 328.0M | 128.7M | 39.3M | 14.9M | 45.8M |
| Total Liabilities | 863.6M | 331.3M | 154.6M | 90.6M | 119.1M |
| Equity | |||||
| Common Stock | 115.0M | 115.0M | 115.0M | 80.0M | 50.0M |
| Retained Earnings | 211.1M | 85.6M | 22.9M | -32.2M | -54.7M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 696.5M | 539.5M | 471.1M | 47.8M | -4.7M |
| Key Metrics | |||||
| Total Debt | 540.3M | 184.1M | 76.9M | 24.5M | 45.3M |
| Working Capital | 368.2M | 317.2M | 376.8M | 31.0M | 4.0M |
Balance Sheet Composition
Trident Lifeline Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 136.1M | 87.0M | 65.8M | 29.8M | 8.5M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -321.3M | -71.6M | -238.8M | -52.3M | -21.3M |
| Operating Cash Flow | -171.6M | 6.8M | -175.9M | -21.2M | -8.7M |
| Investing Activities | |||||
| Capital Expenditures | -111.0M | -178.9M | -69.2M | -4.6M | -5.6M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -86.6M | -4.9M | -33.4M | 0 | 0 |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -197.6M | -183.8M | -102.6M | -4.6M | -5.6M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | 93.2M | 52.4M | 4.4M | - |
| Debt Repayment | - | - | -11.7M | -31.0M | - |
| Financing Cash Flow | 74.6M | 116.1M | 427.5M | 9.3M | 19.0M |
| Free Cash Flow | -213.4M | -156.7M | -259.2M | -6.7M | 9.3M |
| Net Change in Cash | -294.5M | -60.8M | 149.0M | -16.5M | 4.7M |
Cash Flow Trend
Trident Lifeline Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
19.65
Price to Book
3.50
Price to Sales
2.30
PEG Ratio
0.33
Profitability Ratios
Profit Margin
12.58%
Operating Margin
10.24%
Return on Equity
16.87%
Return on Assets
7.53%
Financial Health
Current Ratio
1.78
Debt to Equity
68.64
Beta
-0.20
Per Share Data
EPS (TTM)
₹12.44
Book Value per Share
₹69.84
Revenue per Share
₹109.56
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| TLL | 3.0B | 19.65 | 3.50 | 16.87% | 12.58% | 68.64 |
| Medplus Health | 108.8B | 52.45 | 5.89 | 8.64% | 3.17% | 64.69 |
| One Global Service | 11.0B | 21.06 | 10.22 | 25.75% | 14.00% | 0.03 |
| Sastasundar Ventures | 8.6B | 33.04 | 1.26 | -10.55% | 2.04% | 0.59 |
| Achyut Healthcare | 1.3B | 542.00 | 4.08 | 1.75% | 4.91% | 0.00 |
| Dipna Pharmachem | 228.2M | 10.09 | 0.35 | 4.24% | 1.92% | 23.42 |
Financial data is updated regularly. All figures are in the company's reporting currency.




